E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/9/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Norwood Abbey concludes A$4 million private placement of stock

By Sheri Kasprzak

New York, Aug. 9 - Norwood Abbey Ltd. wrapped a private placement for A$4 million.

The company sold 10.1 million shares of Norwood Immunology Ltd. The exact price per share could not be determined Wednesday.

Based in Melbourne, Australia, Norwood Abbey develops products used in laser eye surgery and other optical procedures.

Issuer:Norwood Abbey Ltd.
Issue:Stock
Amount:A$4 million
Shares:10.1 million
Warrants:No
Settlement date:Aug. 9
Stock symbol:Australia: NAL
Stock price:A$0.175 at close Aug. 9

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.